World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   277 records for 92 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
RecruitingNoCTRI/2017/09/009894
Heat therapy(agnikarma) in Tennis Elbow
22-09-2017 
RecruitingNoNCT03202030
Immediate Dentoalveolar Restoration Compared to Bio-oss
26/06/2017 
RecruitingYesNCT03180424
Impact on Functional Status in Older Adults Treated With L-Carnitine
31/05/2017 
Not RecruitingYesDRKS00011208
UMBRELLA Protocol SIOP-RTSG 2016 - Integrated research and guidelines for standardized diagnostics and therapy of kidney tumours in children, adolescents and young adults
08/05/2017 
RecruitingYesNCT03024996
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2016-001881-27-AT A Study of Atezolizumab (Anti-PD-L1 antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy 19/01/2017 
AuthorisedEUCTR2016-001881-27-CZ A Study of Atezolizumab (Anti-PD-L1 antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy 06/02/2017 
AuthorisedEUCTR2016-001881-27-NL A Study of Atezolizumab (Anti-PD-L1 antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy 25/01/2017 
AuthorisedEUCTR2016-001881-27-PL A Study of Atezolizumab (Anti-PD-L1 antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy 08/02/2017 
AuthorisedEUCTR2016-001881-27-ES A Study of Atezolizumab (Anti-PD-L1 antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy 10/02/2017 
AuthorisedEUCTR2016-001881-27-GB A Study of Atezolizumab (Anti-PD-L1 antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy 27/01/2017 
AuthorisedEUCTR2016-001881-27-DK A Study of Atezolizumab (Anti-PD-L1 antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy 06/02/2017 
AuthorisedEUCTR2016-001881-27-DE A Study of Atezolizumab (Anti-PD-L1 antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy 26/01/2017 
AuthorisedEUCTR2016-001881-27-BE A Study of Atezolizumab (Anti-PD-L1 antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy 08/02/2017 
17/01/2017 
RecruitingNoRBR-7jy2f7
methods of caries removal - A multicenter study
24/10/2016 
Not recruitingYesNCT02789540
Latin American Study of 24-hs Symptoms in Chronic Obstructive Pulmonary Disease (COPD) Patients; LASSYC Study
30/05/2016 
RecruitingNoNCT02765503
Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO Trial
29/04/2016 
Not recruitingYesNCT02730052
Telemonitoring of Uncontrolled Hypertension
28/02/2016 
RecruitingYesISRCTN17756516
The effect of lay health advisor approach of periodontal care intervention for type II diabetes patients
18/11/2015 
      
1 2 3 4 5 6 7 8 9 10
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.3 - Version history